PUMA BIOTECHNOLOGY, INC. PBYI
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2012-03-21
PUMA BIOTECHNOLOGY, INC. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 1,836,213 | $14.9M | 3.63% |
| BlackRock Finance, Inc. | 3,572,806 | $11.6M | 7.05% |
| AQR CAPITAL MANAGEMENT LLC | 725,192 | $5.9M | 1.43% |
| MILLENNIUM MANAGEMENT LLC | 602,240 | $4.9M | 1.19% |
| D. E. Shaw & Co., Inc. | 316,343 | $2.6M | 0.62% |
| TWO SIGMA INVESTMENTS, LP | 140,587 | $1.1M | 0.28% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.